About conolidine
Within a the latest study, we documented the identification and also the characterization of a completely new atypical opioid receptor with special adverse regulatory Homes to opioid peptides.1 Our success showed that ACKR3/CXCR7, hitherto called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can be a broad-spectrum scavenger for